Delivery Order SPE2DB25D2204-SPE2DB25FTGQH

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wezlana 90 mg/ml syringes, a medical product, with a ceiling value of $16,343.41. The contract is a firm fixed price, non-set-aside award with a period of performance through June 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "WEZLANA 90 MG/ML SYRINGEML", a pharmaceutical product, with a firm fixed price ceiling value of $68,269.63. The contract has an ultimate completion date of June 6, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corporation holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of WEZLANA 90 MG/ML SYRINGE. The contract has a ceiling value of $29,561.01 and is a Firm Fixed Price type. It has an ultimate completion date of June 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,857.14, is for the delivery of 4,568,105,667 units of Wezlana 90 mg/ml syringes. The contract is a firm fixed-price delivery order, with a performance period ending on May 2, 2025. This contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,526.94 firm fixed-price delivery order is for the supply of 4,568,040,348 units of Wezlana 90 mg/ml syringes. The contract has an ultimate completion date of April 28, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,568.57, is for the delivery of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract has a completion date of June 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $13,099.49. The contract is a Firm Fixed Price contract, with a period of performance through May 29, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wezlana 130 mg/26 ml vials, a medical product. The contract has a ceiling value of $5,519.36 and is a firm fixed price, non-set-aside contract. The performance period extends through May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a $24,411.25 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of WEZLANA 90 MG/ML SYRINGEML. The contract has an ultimate completion date of May 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price of $66,722.04 and a period of performance through June 5, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB25D2204
    Indefinite Delivery Contract
  • SPE2DB25D2204-SPE2DB25FTGQH
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Wezlana 90 mg/ml syringes. The contract has a ceiling value of $30,439.86 and a completion date of June 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract, indicating open competition. The contract allows for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide, positioning Amerisourcebergen as a critical vendor in meeting federal medical procurement needs.

Generated 9/14/25, 12:58 AM